Table 2. Summary statistics of the transcriptome sequencing.

Patient	Differentiation grade	Sample Type	Total reads	Mapped reads	Total base (bp)	Mapped base (bp)	Mappping ratio	Coverage (X)
P1	Poorly	T	35,930,408	33,819,287	4,491,301,000	4,227,410,875	94.12%	33
		N	34,902,228	32,863,973	4,362,778,500	4,107,996,625	94.16%	32
P2	Poorly	T	35,315,378	33,125,921	4,414,422,250	4,140,740,125	93.80%	32
		N	34,383,802	32,279,443	4,297,975,250	4,034,930,375	93.88%	31
P3	Poorly	T	35,532,658	33,258,212	4,441,582,250	4,157,276,500	93.60%	32
		N	34,537,914	32,152,860	4,317,239,250	4,019,107,500	93.09%	31
M1	Moderately	T	34,566,526	32,670,216	4,320,815,750	4,083,777,000	94.51%	31
		N	35,384,486	33,407,169	4,423,060,750	4,175,896,125	94.41%	32
M2	Moderately	T	34,564,642	32,385,294	4,320,580,250	4,048,161,750	93.69%	31
		N	34,771,048	32,792,475	4,346,381,000	4,099,059,375	94.31%	32
M3	Moderately	T	35,371,920	32,571,695	4,421,490,000	4,071,461,875	92.08%	31
		N	35,959,532	32,990,753	4,494,941,500	4,123,844,125	91.74%	32
W1	Well	T	34,762,386	32,701,011	4,345,298,250	4,087,626,375	94.07%	31
		N	35,314,918	33,021,170	4,414,364,750	4,127,646,250	93.50%	32
W2	Well	T	35,610,444	32,509,118	4,451,305,500	4,063,639,750	91.29%	31
		N	34,637,398	31,280,461	4,329,674,750	3,910,057,625	90.31%	30
W3	Well	T	42,279,434	39,097,967	5,284,929,250	4,887,245,875	92.50%	38
		N	40,083,384	36,852,292	5,010,423,000	4,606,536,500	91.90%	35
Average			35,772,695	33,321,073	4,471,586,847	4,165,134,146	93.17%	32

Note: T and N represent tumor and adjacent non-tumor tissue, respectively.